Skip to main content
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. logo

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. — Investor Relations & Filings

Ticker · 2291 ISIN · CNE1000057M5 HKEX Manufacturing
Open in API
Filings indexed 151 across all filing types
Latest filing 2026-05-22 Notice of Dividend Amou…
Country HK Hong Kong
Listing HKEX 2291

About LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.

http://www.scientechmed.com

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. specializes in the research, development, manufacturing, and commercialization of advanced interventional medical devices. The core focus is on structural heart diseases, encompassing solutions for congenital heart defects, heart valve conditions, and the prevention of cardiogenic stroke. The company's product portfolio includes specialized interventional treatment series, such as coronary heart disease occluder products and heart valve medical devices. Leveraging innovation in interventional cardiology, the company aims to provide comprehensive healthcare solutions for complex structural heart conditions globally.

Recent filings

Filing Released Lang Actions
Final Dividend for the year ended 31 December 2025 (updated)
Notice of Dividend Amount Classification · 93% confidence The document is a formal announcement titled “Cash Dividend Announcement for Equity Issuer” detailing the final dividend amount, currency, record dates, ex-dividend date, payment date, and related withholding tax information for the year ended 31 December 2025. This fits the definition of a Notice of Dividend Amount, which provides dividend details and timelines.
2026-05-22 English
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 22, 2026 (2) PAYMENT OF FINAL DIVIDEND
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is an official announcement of the poll results from the Annual General Meeting held on May 22, 2026, including detailed vote counts for each resolution, followed by details of the approved final dividend payment. This aligns with the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-22 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for the month ended 30 April 2026. It details movements in authorized/registered share capital, issued shares, treasury shares, public float sufficiency confirmation, and confirms compliance with listing rules. It is a regulatory compliance report related to share capital and public float status, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. It is a regulatory filing specific to share capital movements and confirmations under HKEX rules, fitting the category of Regulatory Filings (RNS). The document length (8280 characters) and content confirm it is not a brief announcement but a detailed regulatory submission, yet it is not a financial report or other specific category. Therefore, the best classification is Regulatory Filings (RNS).
2026-05-07 English
Final Dividend for the year ended 31 December 2025 (updated)
Notice of Dividend Amount Classification · 90% confidence The document is an official announcement by a Hong Kong listed issuer detailing a final cash dividend for the year ended 31 December 2025, including the dividend amount per share, ex-dividend date, record date, payment date, withholding tax details, and other dividend logistics. This precisely matches the definition of a Notice of Dividend Amount (Code: DIV).
2026-04-23 English
PROXY FORM FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 22, 2026 OR ANY ADJOURNMENT THEREOF
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a proxy form for the 2025 Annual General Meeting, providing shareholders with materials to appoint proxies and cast votes in advance. This is a solicitation of shareholder votes and falls under materials sent to shareholders to request votes for a meeting, which matches the Proxy Solicitation & Information Statement category (PSI).
2026-04-23 English
NOTICE OF THE 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 85% confidence The document is the formal “Notice of the 2025 Annual General Meeting,” listing resolutions to be voted on, proxy appointment details, meeting date and venue, and instructions for shareholders to submit proxies. It is sent to shareholders to provide meeting information and solicit votes, matching “Proxy Solicitation & Information Statement (PSI).”
2026-04-23 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.